In practice, authors often argue about a potential biomarker's clinical use based on its highly significant p ‐value disregarding an inadequate number of analyzed samples.
1
—
—
In practice, authors often argue about a potential biomarker's clinical use based on its highly significant p ‐value disregarding an inadequate number of analyzed samples.